Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.24 -0.26 (-1.68%)
As of: Nov 11, 2026 · 3:59 PM EST

Ascentage Pharma Group International (AAPG) Current Deferred Tax Assets (2023 - 2026)

Updated

Ascentage Pharma Group International's Current Deferred Tax Assets was $60.39 million in Q2 2026, down 35.4% from $93.45 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Current Deferred Tax Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Current Deferred Tax Assets at Ascentage Pharma Group International came in at $186.01 million, up 341.5% from FY2024.

  • In earlier years, Current Deferred Tax Assets was $42.13 million in FY2024 (-27.0%) and $57.69 million in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Current Deferred Tax Assets since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Ascentage Pharma Group International 1.42 Bn 382.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.39 Mn
Dec 31, 2025 185.93 Mn
Jun 30, 2025 93.45 Mn
Dec 31, 2024 42.14 Mn
Dec 31, 2023 57.69 Mn
API Access

Ascentage Pharma Group International Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=AAPG&period=max&api_key=YOUR_API_KEY